Topical compositions and methods of treatment of anorectal disorders
A topical anorectal composition includes trimethylsiloxysilicate; at least one surfactant selected from the group consisting of sodium lauryl sulfate, alkyl- and alkoxy-dimethicone copolyol, polysorbate and a combination thereof; a non-polar volatile siloxane solvent; at least 15% (w/w) water, and a pharmaceutical agent selected from the group consisting of pramoxine, phenylephrine, hydrocortisone, salicylic acid, nitroglycerine, sildenafil, or their salts and combinations thereof, wherein the composition is sufficiently designed to dry within 60 seconds after application to the anorectal mucosa to form a dried composition, and wherein the dried composition forms: a flexible film, wherein the flexible film closely follows irregularities of the body surface as well as movement of the body surface, and (ii) a durable film, wherein the durable film does not crack or flake off and remains intact for more than 12 hours giving release of the pharmaceutical agent for an extended period of time.
1. A topical anorectal composition comprising:
25.0% (w/w) of trimethylsiloxysilicate; from 1.0% (w/w) to 5.0% (w/w) of at least one surfactant selected from the group consisting of sodium lauryl sulfate, alkyl- and alkoxy-dimethicone copolyol, polysorbate and a combination thereof, from 15.0% (w/w) to 40.0% (w/w) of water, from 30.0% (w/w) to 50.0% (w/w) of methylsiloxane; and from 0.005% (w/w) to 25.0% (w/w) of at least one pharmaceutical agent; wherein the composition is in a form selected from the group consisting of a gel and a liquid emulsion, wherein the gel comprises a sufficient amount of at least one gelling agent so that the composition is in the form of a gel, and wherein the liquid emulsion is provided as an impregnated wipe or an impregnated towellete.
2. The composition of claim 1 wherein the at least one pharmaceutical agent is selected from the group consisting of pramoxine, phenylephrine, hydrocortisone, salicylic acid, nitroglycerine, sildenafil, procaine, lidocaine, tetracaine, dibucaine, prilocaine, phenacaine, benzyl alcohol, benzocaine, diperodon, dyclonine, dimethisoquin, epinephrine, tetrahydrozoline hydrochloride, an amphetamine, an antihistamine, methylphenidate, mephedrone, oxymetazoline, pseudoephedrine, psilocybin, ephedrine sulfate or their salts and combinations thereof.
3. The composition of claim 1 wherein essentially free of preservatives.
4. The composition of claim 1 in the form of a gel.
5. The composition of claim 1 in the form of a liquid emulsion.
6. The composition of claim 1 wherein the at least one surfactant is a polysorbate.
7. The composition of claim 1 further comprising an additive selected from the group consisting of a dimethicone/vinyl dimethicone crosspolymer, a silicone gum blend, a gelling agent, and a combination thereof.
8. The composition of claim 1 further comprising a buffering agent to adjust the pH of the composition to a pH of about 4.2-4.4.
9. The composition of claim 1 further comprising an organosilicone surfactant.
10. The composition of claim 1 further comprising a viscosity modifier.
11. The composition of claim 1 comprising:
25.0% (w/w) of trimethylsiloxysilicate;
from 1.0% (w/w) to 5.0% (w/w) of polyoxyethylene sorbitan monooleate;
from 30.0% (w/w) to 50.0% (w/w) of methylsiloxane;
from 15% (w/w) to 40% (w/w) of water;
1.0% (w/w) pramoxine; and 0.25% (w/w) phenylephrine.
12. A method of treating an anorectal disorder comprising topically applying once daily to the mucosal surface of an anorectal region of a subject in need of such treatment a therapeutically effective amount of the composition of claim 1 wherein the anorectal disorders is selected from the group consisting of hemorrhoids, anal fissures, anal cracks, anal fistulas, anal abscesses, and anal pruritus.
13. A method of treating an anorectal disorder comprising topically applying once every other day to the mucosal surface of an anorectal region of a subject in need of such treatment a therapeutically effective concentration of the composition of claim 1 wherein the anorectal disorders is selected from the group consisting of hemorrhoids, anal fissures, anal cracks, anal fistulas, anal abscesses, and anal pruritus.
14. A method of treating an anorectal disorder comprising topically applying twice weekly to the mucosal surface of an anorectal region of a subject in need of such treatment a therapeutically effective concentration of the composition of claim 1 wherein the anorectal disorders is selected from the group consisting of hemorrhoids, anal fissures, anal cracks, anal fistulas, anal abscesses, and anal pruritus.
15. A kit comprising the composition of claim 1 and a container-applicator device suitable for storage and application of the composition to the anorectal region.
16. The kit according to claim 15 wherein the container-applicator device is selected from the group consisting of a single use wipe, a syringe, a dropper, a spray dispenser, a compressible bottle or tube, a spatula, a suppository insertion tube, an extrusion tube, and an inflatable member.